Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Controls to Ensure Consistent Quality and Optimal Performance of TCR and BCR Profiling Assays

The first-to-market DriverMap™ AIR RNA TCR/BCR spike-in calibration controls measure the accuracy, sensitivity, and linear range of sequencing-based immune repertoire profiling assays. MOUNTAIN VIEW, Calif., April 4, 2024 /PRNewswire/ — Cellecta, Inc. today announced the launch of the…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks